Sign inJoin waitlistJoin the waitlist

Christopher Polk

Associate Professor, Infectious Diseases, Internal Medicine · Wake Forest University Baptist Medical Center

Credentials: · · · · ·

History

Wake Forest University Baptist Medical Center
Present

Infectious Disease
UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION
2004–2006
Internal Medicine
UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION
2001–2004
University of Texas Medical Branch at Galveston School of Medicine
1997–2001

Research

Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
Antimicrobial Agents and Chemotherapy · 2020 · Last of 7 authors · 158 citations
Skin and Soft Tissue Infections in Patients with Diabetes Mellitus
Review · Infectious Disease Clinics of North America · 2021 · First of 4 authors · 63 citations
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective,…
The Lancet Infectious Diseases · 2025 · 62 citations

Michael Leonard
8 papers
Mindy Sampson
7 papers
Katie Passaretti
6 papers
Andrew Badley
3 papers
Colleen Kelley
3 papers
Lisa Davidson
3 papers
Vincent Marconi
3 papers
Zelalem Temesgen
3 papers
Charles Burger
2 papers
CL
Claudia Libertin
2 papers
Graeme Forrest
2 papers
Jason Baker
2 papers

Clinical trials

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
Principal investigator · Withdrawn · Phase 4
Wake Forest University Health Sciences
2021–2023